OverviewChartNewsTraderScreen

BNP Paribas Aktienanleihe SNW 27..../  DE000PN5LHP4  /

EUWAX
2024-05-30  9:17:19 AM Chg.-0.13 Bid9:55:04 PM Ask9:55:04 PM Underlying Strike price Expiration date Option type
88.88EUR -0.15% 89.06
Bid Size: 20,000		 89.16
Ask Size: 20,000		 SANOFI SA INHABER ... 100.00 EUR 2024-06-27 Call
GlobeNewswire 10:05 PM Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire 6:15 PM OSE Immunotherapeutics Provides Business and Corporate Update
GlobeNewswire 3:01 PM Press Release: Sanofi completes acquisition of Inhibrx, Inc.
GlobeNewswire 1:00 PM SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire 05-27 Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire 05-23 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 05-21 Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
GlobeNewswire 05-20 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire 05-20 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire 05-20 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire 05-13 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire 05-13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
TeleTrader 05-13 Europe mixed at open as CPI prints loom
GlobeNewswire 05-13 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
TeleTrader 05-10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 05-10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 05-10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 05-09 Europe opens mixed with BoE in focus
GlobeNewswire 05-08 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-07 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 05-02 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 04-25 Europe opens mostly down after corporate earnings